Relationship between CRP and clinical course of unstable angina depends on assay method

Vascular Pharmacology

Volumn 39, Issue 3, 2002, Pages 113-115

  De Maat, Moniek P M ^a   Haverkate, Frits ^a   Kluft, Cornelis ^a  

^a TNO   (Netherlands)

Author keywords

Assay; CRP; Unstable angina

Indexed keywords

C REACTIVE PROTEIN; POLYCLONAL ANTIBODY;

ACCURACY; ANALYTIC METHOD; CALCULATION; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEPHELOMETRY; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; BIOLOGICAL ASSAY; C-REACTIVE PROTEIN; HUMANS;

EID: 0036706272     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00296-3     Document Type: Conference Paper

References (4)

1. Danesh J., Whincup P., Walker M.et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Brit. Med. J. 321:2000;199-204.
2. Haverkate F., Thompson S.G., Pyke S.D.et al. Production of C-Reactive Protein and risk of coronary events in stable and unstable angina. (European Concerted Action on Thrombosis and Disabilities, Angina Pectoris Study Group). The Lancet. 349:1997;462-466.
3. Roberts W.L., Moulton L., Law T.C.et al. Evaluation of nine automated high-sensitivity c-reactive protein methods: implications for clinical and epidemiological applications, (part 2). Clin. Chem. 47:2001;418-425.
4. Verheggen P.W.H.M., Demaat M.P.M., Manger Cats V.et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. Eur. Heart J. 20:1999;567-574.